- The cohort consisted of 300 patients enrolled in the IPF-PRO Registry (NCT01915511) between June 2014 and February 2017. Patients with idiopathic pulmonary fibrosis (IPF) that was diagnosed or confirmed at the enrolling center within the past 6 months were eligible for enrollment. This analysis included patients who had enrollment blood samples and data on critical clinical variables at enrollment (age, sex, height, smoking status, definite/probable/possible IPF according to the 2011 ATS/ERS/JRS/ALAT diagnostic criteria, spirometry). Outcomes were ascertained from enrollment through June 2019. Matrix metalloproteinases (MMPs) 1, 2, 3, 7, 8, 9, 12, 13 and tissue inhibitors of matrix metalloproteinases (TIMPs) 1, 2, and 4 were quantified ... [Read More]
- Total Size
- 3 files (292 KB)
- Data Citation
- Amubieya, O., Todd, J. L., Neely, M. L., Kaner, R. J., Lasky, J. A., Namen, A., Hesslinger, C., Palmer, S. M., Weigt, S. S., & Belperio, J. A. (2024). Data from: Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. Duke Research Data Repository. https://doi.org/10.7924/r4ff40891
- Creator
- DOI
- 10.7924/r4ff40891
- Publication Date
- August 28, 2024
- ARK
- ark:/87924/r4ff40891
- Affiliation
- Publisher
- Type
- Contact
- Megan L. Neely, megan.neely@duke.edu, 919-684-8783, https://orcid.org/0000-0002-0101-1081
- Title
- Data from: Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
- Repository
| Thumbnail | Title | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|
|
ipfbio_tmpmmp_plos_data.csv | 2024-08-28 | Download | |
|
ipfbio_tmpmmp_plos_data.sas7bdat | 2024-08-28 | Download | |
|
|
ipfbio_tmpmmp_plos_data_dictionary.pdf | 2024-08-28 | Download |